SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
October 15, 2021 —
SNMMI Urges Congress to Avert Cuts to Physician Reimbursement
Yesterday, SNMMI and more than 200 other medical societies espoused their support for averting cuts to the Medicare Physician Fee Schedule (MPFS). Reps. Bera (D-CA) and Buschon (R-IN) led this effort in the following "Dear Colleague" letter to House leadership, supported by 245 members of Congress.
September 26, 2021 —
The FIND Act Gets a Senate Companion Bill
On August 4, 2021, Senators Marsha Blackburn (R-TN) and Tammy Baldwin (D-WI) introduced the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609), legislation that would significantly expand patient access to advanced nuclear diagnostic imaging technologies.
September 3, 2021 —
ACMUI Backs SNMMI's Recommendations on Extravasation Reporting
Yesterday, the ACMUI Subcommittee on Extravasations reviewed and provided further recommendations on the NRC Staff Preliminary Evaluation of Radiopharmaceutical Extravasation and Medical Event Reporting in a public meeting. In anticipation of the meeting, SNMMI provided public comment.
August 12, 2021 —
California Members: Act Now to Oppose A.B 1273
Earlier this year, Assemblyman Freddie Rodriguez introduced A.B 1273, Interagency Advisory Committee on Apprenticeship: the Director of Consumer Affairs and the State Public Health Officer. Our SNMMI-TS Advocacy Committee acted quickly and submitted an opposition letter prior to the public hearing before the Senate Health Committee. This harmful piece of legislation is now up for a (Senate) floor vote, so we are calling our members to act quickly to oppose it.
July 26, 2021 —
SNMMI Comments on CURES 2.0 Proposal
When Reps. Upton and DeGette requested comment on their 21st Century Cures 2.0 proposal, we listened. The bill aims to continue the acceleration of the discovery, development, and delivery of 21st century cures. The coalition's letter urged Congress to use this opportunity to expand Medicare beneficiary access to diagnostic radiopharmaceuticals.
July 21, 2021 —
SNMMI and Coalition Partners Applaud the Introduction of the FIND Act
On July 16, Congressmen Scott Peters (D-CA), Bobby Rush (D-IL), Neal Dunn (R-FL) and Greg Murphy (R-NC) introduced the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 4479), legislation that would significantly expand patient access to advanced nuclear diagnostic imaging technologies.